HEALTH TECHNOLOGY

Olive Announces the Availability of Olive Helps and a New Loop Development Kit, That Use Cybernetics to Deliver Real-Time Healthcare Insights

Olive | July 30, 2021

Olive, the Internet of Healthcare automation startup, today announced the general availability of Olive Helps, healthcare's AI coworker that improves the speed, quality, and impact of healthcare workers. Olive, a cybernetic application, uses its platform to harness the intelligence of the healthcare community to bridge the gap between work and wisdom for healthcare professionals.

 

Healthcare workers are often bombarded with information and face workflow interruptions due to using many different technological platforms. Olive assists in reducing these workflow barriers by delivering real-time intelligence that enables humans to work better and faster.

 

Olive is a lightweight desktop application that detects a healthcare worker's needs through "Loops" and displays the relevant information at the appropriate time. Loops are applications that silently operate on the platform to provide humans with real-time intelligence. They are created by an ecosystem of partners, including Olive, technology developers, and health systems, accessible through the Loop Library. Like applications in an app store, loops in the Loop Library are produced by platform and app developer partners.

 

Using the Loop Development Kit, we're creating the first true healthcare platform.

 

Olive Helps is the first real healthcare platform with a developer ecosystem. Unlike closed-end software marketplaces, anybody can create Loops for health systems and hospitals using Olive's Loop Development Kit (LDK).

 

Olive Helps is supercharging the healthcare profession by using real-time intelligence through these Loops, increasing worker ROI while reducing burnout. In addition, olive Helps is collaborating with an ecosystem of technology partners to address healthcare's most important concerns, including:

  • ASUS, a global electronics company with an expanding range of healthcare products and services, now offers the AI medical coding assistance ASUS Miraico via Olive Helps, allowing healthcare professionals to reduce their medical coding workload.
  • Dignity Health Global Education, a renowned healthcare workforce development business committed to delivering customized educational opportunities and a student-centric experience, offers its expertise to market through Olive Helps.
  • Ribbon Health, a healthcare data platform that provides complete, real-time information about providers, insurance plans, locations, and more through the Olive Helps Provider Directory Loop.
  • Adaptrack, Welcome Home Health, Telespine, Clear Child Psychology, ScaleHealth, Rotera, Well Advised, Amend Health, Advocatia, Louvir, and others join Olive Helps regularly.

 

Olive Helps is already assisting health systems in saving time and growing. For example, when Olive Helps was implemented at a health system's call center in California, it shaved a full minute off typical call times, saving 12.5%, reducing patient wait times, providing them the assistance they need faster, and enhancing their overall experience. In addition, olive Helps has shown to be a 10x better experience for patient access and triage team members, resulting in quicker onboarding and an overall improvement in job satisfaction. This has resulted in $1.9 million in revenue savings and growth for the health system.

 

The platform was named "Best Intelligent Personal Assistant" by the AI Breakthrough Awards, a testament to the cutting-edge technology used in Olive Helps. The annual AI Breakthrough Awards are presented to companies breaking through the AI clutter and delivering significant results for the organizations with whom they collaborate.

 

About Olive

Olive is an automation company that is leading the Internet of Healthcare. Through automation, the company addresses the most challenging healthcare problems, providing greater revenue, lower expenses, and better efficiency to hospitals, health systems, and payers. People are unhappy with the system today, and healthcare workers are essentially working in the dark due to outdated technology, which leads to a lack of shared knowledge and siloed data. Olive is bridging gaps to provide new light on healthcare processes, enhancing operations today so that everyone can benefit from a healthier industry tomorrow.
 

Spotlight

At Stratford Court of Boca Pointe, our Memory Care neighborhood works to create a stimulating, comfortable and safe environment for residents experiencing Alzheimer's, dementia or other forms of memory loss. To learn more about memory care at Stratford Court of Boca Pointe, please visit http://www.sunriseseniorliving.com/co.


Other News
HEALTH TECHNOLOGY

Netsmart and Bamboo Health Collaborate to Champion Care Coordination and Crisis Management

Netsmart | April 12, 2022

Netsmart announced a partnership with Bamboo Health, a leading provider of data and healthcare IT solutions, to create a comprehensive behavioral health referral network supporting the nationwide effort to respond to the need to implement a 988 crisis management system. Through this strategic technology partnership, Netsmart and Bamboo Health will partner to create one of the most robust crisis management solutions in the market. The integrated solution will expedite access to treatment for those in crisis, connect individuals to a network of care and enable effective post-crisis care coordination. Netsmart will integrate the Bamboo Health OpenBeds solution within the CareManager™ population health management platform, currently utilized by many health home organizations, managed care organizations, human services and post-acute care providers across the country. By working together to connect healthcare providers, emergency departments and crisis response professionals across a national network, OpenBeds and Netsmart will deliver an advanced system to help states, counties and providers respond to 988 and crisis line demands. Streamlining mobile crisis service coordination, treatment facility bed availability, electronic transfers and referrals to behavioral health services, the solution will create a full-picture view of an individual’s journey, including health history and treatment and services, making it easier for providers to get patients engaged with the right level of care they need quickly. Netsmart and Bamboo Health are excited to announce that the Missouri Behavioral Health Council will be deploying the solution as part of a statewide approach to create a comprehensive statewide crisis network (known as Missouri Behavioral Health Connect – MOConnect). MOConnect will support crisis management for the Missouri Department of Mental Health, Missouri Behavioral Health Council (MBHC) and its member organizations, and community response and health partners across the state. With the vision of MBHC and its members, Missouri Behavioral Health Connect will validate the value of an integrated and connected statewide approach to crisis management and care coordination. “By collaborating with Netsmart, together we will be able to strengthen our statewide networks to effectively manage and respond to crisis by integrating our OpenBeds solution within the CareManager population health and care coordination platform,” said Bamboo Health CEO Rob Cohen. “Through this innovative technology initiative, we can leverage one of the largest community-based interoperability networks in the country to connect with the larger healthcare ecosystem. Together, we enable care coordination and leverage robust data and analytics for population health management that improves patient outcomes during and post-crisis.” MBHC, a longtime partner of Netsmart, leverages many components of the CareFabric platform and began using CareManager to eliminate data silos and streamline the complex process of operationalizing population health management in 2016. MBHC members have significantly advanced their workflows using CareManager and have expanded their use cases within the platform to additional programs, including the CCBHC model which is transforming service delivery for Community Mental Health Centers across the country. “We are excited to be a part of this unique partnership and continue to leverage technology to enable our award-winning care teams across the state with the right technology to support delivering the best care. In Missouri, we are going ‘Beyond the Call’ in our approach to implementing the 988 Crisis Hotline by working together with all stakeholders to ensure individuals in need have not just someone to call in their time of need but connecting them to resources to enable better long term outcomes. By approaching the rollout of a comprehensive crisis system in the context of all of the behavioral health initiatives underway in Missouri, including the CCBHC model, we can make this happen.” MBHC CEO & President Brent McGinty The CCBHC model enables agencies to deliver a comprehensive range of physical, mental health and substance use treatment and services, providing expanded care while helping lower costs across the behavioral health ecosystem. Behavioral health providers that achieve CCBHC certification are uniquely positioned to serve as a foundation for the nation’s new crisis response system and Missouri has led the way in proving the value of the CCBHC initiative. “We are thrilled to announce our new partnership with Bamboo Health, as we collectively redefine how states facilitate crisis management,” said Netsmart CEO Mike Valentine. “We believe teaming up with industry-leading technology providers to further extend the value of our CareFabric platform demonstrates our commitment to innovation and collaboration to meet our clients’ needs. As a longtime partner of MBHC and advocate for CCBHC funding, we couldn’t be happier to see this project come to life and continue to enhance this and other statewide efforts.” To hear more about the Netsmart, Bamboo Health and MBHC strategic technology partnership stop by the Netsmart booth 313 at the National Council of Mental Wellbeing Conference (NATCON22) in Washington, D.C., April 11 – 13. About Bamboo Health Bamboo Health is a healthcare technology solutions company, focused on fostering care collaboration and providing information and actionable insights across the entire continuum of care. As one of the largest, most diverse care collaboration networks in the country, our technology solutions equip healthcare providers and payers with software, information, and insights to facilitate whole person care across the physical and behavioral health spectrums. By serving 2,500 hospitals, 8,000 post-acute facilities, 25,000 pharmacies, 32 health plans, 50 state governments, and over one million acute and ambulatory providers through more than 500 clinical information systems electronically, we impact over 1 billion patient encounters annually in provider workflow. Health systems, payers, providers, pharmacies, governments, individuals, and other organizations rely on Bamboo Health to improve care and reduce cost. Connect with Bamboo Health on Twitter, LinkedIn and Facebook. Visit www.BambooHealth.com to learn more. About Missouri Behavioral Health Council The Missouri Behavioral Health Council’s mission is to enable access to quality mental health services to all Missouri citizens in need of such services, while maximizing their human potential and quality of life. This mission will be accomplished through the continued maintenance and development of a stable statewide network of comprehensive community based behavioral healthcare. About Netsmart Netsmart, a leading provider of Software as a Service (SaaS) technology and services solutions, designs, builds and delivers electronic health records (EHRs), health information exchanges, analytics and telehealth solutions and services that are powerful, intuitive and easy-to-use. Our platform provides accurate, up-to-date information that is easily accessible to care team members in the human services and post-acute care (which is comprised of home care and hospice and senior living) markets. We make the complex simple and personalized so our clients can concentrate on what they do best: provide services and treatment that support whole-person care.

Read More

FUTURE OF HEALTHCARE

GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate

GeneQuantum Healthcare | April 19, 2022

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQuantum focuses on next generation Antibody Drug Conjugate development. Taking advantage of the proprietary 'Ligase Dependent Conjugation' technology platform, which allows a site-specific conjugation of cytotoxins or other type of payloads to antibodies, the company has successfully developed a robust pipeline with more than 10 assets, with several at or approaching clinical stage. In addition to expanding the unique technology platform, the company has entered into a number of partnerships with domestic biotech/pharmaceutical companies and international partners. The growing number of partnerships speaks to the power of the GeneQuantum platform technology for not only improving key therapeutic characteristics of existing molecules, but also for creating new classes of molecules, ultimately increasing the number of available treatment options for patients worldwide. GeneQuantum is excited about the significant potential of partnerships with business partners and will continue to expand its deal pipeline in the antibody drug conjugate and protein therapeutic market. The collaborating ADC is a first-in-class asset with highly differentiated antibody against a unique target, a stable linker design and a novel payload with a strong by-stander killing effect. The resulting ADC is expected to treat brain and other cancers with huge unmet needs. "As an innovative antibody+ company, we look for complementary partners to maximize value of our platform technology. Aimed Bio not only has differentiated antibody acting on a unique target but also has deep knowledge and expertise in the field of brain tumor & CNS diseases. This collaboration is based on an excellent match between the two companies to generate a FIC ADC. Through close partnership, we are thrilled to bring revolutionary therapy for those patients without efficient treatment at this moment." Dr. Gang Qin, the Founder & Chairman, CEO of GeneQuantum Dr. Dohyun Nam, the Founder & Chairman, CTO of Aimed Bio and internationally renowned neurosurgeon with 32 years of experience in brain tumor & CNS diseases commented: "Aimed Bio has been successfully expanding its R&D pipeline for the past 2 years, and I am pleased to start this collaboration with GeneQuantum. After evaluating the data, the linker-payload and conjugation technology GeneQuantum provides proved to be very safe and effective. With the best antibody and brain tumor expertise of Aimed Bio, I believe the collaborating ADC will bring a tremendous impact on the field. We look forward to initiating clinical trial as soon as possible." About GeneQuantum Healthcare Co., Ltd. GeneQuantum Healthcare Co., Ltd. is a high-tech biopharmaceutical company dedicated to the development of innovative biotherapeutics. The company is focused on the development of a next generation of bioconjugate therapeutics to meet the unmet medical needs of cancer patients globally. For more information, visit www.genequantum.com. About AIMEDBIO Inc. AIMEDBIO is a spin-off company from Samsung Medical Center established in August 2018. AIMEDBIO aims to provide therapeutic solutions to patients with serious brain diseases, including neuro-oncological and -degenerative diseases, to save patients' lives and improve patients' quality of life. Based on solid global networks with key opinion leaders in the field, an excellent research team with profound achievements, and R&D pipelines with an outstanding drug development platform, AIMEDBIO is an emerging leader for development of innovative therapeutics against diverse brain diseases.

Read More

MEDICAL DEVICES

BD Acquires Scanwell Health, Inc. to Expand and Scale Digital At-Home Testing

BD | December 22, 2021

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in smartphone-enabled at-home medical tests.BD collaborated with Scanwell to develop the app used with the recently launched BD Veritor™ At-Home COVID-19 Test, the first at-home COVID-19 test that uniquely uses a smartphone camera and app to capture and interpret results, eliminating the human subjectivity in other visually read at-home antigen tests. Scanwell will become the foundational digital platform upon which BD plans to develop at-home diagnostic tests for a range of infectious diseases including COVID-19/influenza A+B, group A strep and additional menu for detecting infections and managing chronic disease. "The COVID-19 pandemic has accelerated the shift to new care settings, and BD is ready to deliver a smart, connected at-home diagnostic ecosystem to support traditional and telehealth providers and consumers. This acquisition will enable us to expand and scale our digital capabilities in-house to speed time to market for transformative at-home solutions now and in the future." Dave Hickey, president of Life Sciences for BD The Scanwell app is a key differentiator in the market for at-home COVID-19 testing. To date, no other company uses the phone's camera to capture the image of the test that is then analyzed and interpreted by the app. Other COVID-19 home tests use smartphones as part of their process, but BD Veritor™ At-Home COVID-19 Test is the first and only test to use the smartphone as the analyzer to digitally interpret the test results and provide a definitive POSITIVE or NEGATIVE digital display of testing results. The app also has the capabilities to securely store and report test results to organizations, including businesses, public health authorities and schools. The results of tests are stored in the app and can be referenced and displayed at any time by simply logging into the app. Terms of the transaction were not disclosed. The transaction is expected to be immaterial to BD's fiscal 2022 financial results. Scanwell financial results will be reported under the Integrated Diagnostic Solutions business within the Life Sciences segment. About the BD Veritor™ At-Home COVID-19 Test The BD Veritor™ At-Home COVID-19 Test has not been FDA cleared or approved; but has been authorized by FDA under Emergency Use Authorization (EUA). This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Read More

FUTURE OF HEALTHCARE

Rockley Photonics and Medtronic Collaborate to Deliver the Next Generation of Wearable Healthcare Monitoring Devices

Rockley Photonics | March 11, 2022

Rockley Photonics Holdings Limited a global leader in photonics-based health monitoring and communications solutions, announced that it has agreed to enter a development partnership with Medtronic, a global leader in healthcare technology. The two companies plan to collaborate to bring Rockley’s recently announced Bioptx™ biomarker sensing platform into Medtronic’s solutions for use across various healthcare settings. Rockley’s biosensing technology is expected to expand the capabilities of wearable medtech devices by miniaturizing the measurement and analysis of a range of biomarkers into a compact form factor. These advances mean that a single wearable device could monitor multiple crucial biomarkers – including core body temperature, blood pressure, body hydration, alcohol, lactate, and glucose trends, among others. The Bioptx platform offers an end-to-end sensing solution that integrates cloud analytics and artificial intelligence (AI) to potentially deliver a holistic assessment of a variety of conditions. The partnership with Medtronic builds on the societal shift from reactive to proactive healthcare by potentially enabling round-the-clock, real-time, non-invasive monitoring of a person’s health and well-being, thereby empowering clinicians to personalize care with actionable data. “This partnership combines Medtronic’s exceptional strength in providing in-patient care with Rockley’s expertise in wearable, remote monitoring. I believe that this collaboration will bring to life our vision of giving people better insights into their health and well-being. We are excited about the potential for this partnership to herald the next generation of wearable devices and deliver a complete lifecycle of patient care.” Dr. Andrew Rickman, chairman and chief executive officer of Rockley About Rockley Photonics A global leader in photonics-based health monitoring and communications solutions, Rockley Photonics is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.

Read More

Spotlight

At Stratford Court of Boca Pointe, our Memory Care neighborhood works to create a stimulating, comfortable and safe environment for residents experiencing Alzheimer's, dementia or other forms of memory loss. To learn more about memory care at Stratford Court of Boca Pointe, please visit http://www.sunriseseniorliving.com/co.

Resources